Evogene Appoints Prof. John Irwin and Prof.

Core Insights - Evogene Ltd. has appointed Prof. John J. Irwin and Prof. Dan T. Major to its Scientific Advisory Board, enhancing its scientific leadership and supporting the advancement of ChemPass AI™ for drug and ag-chemical discovery [1][2][3] Company Overview - Evogene Ltd. is a leading computational chemistry company focused on AI-driven discovery and design of novel small molecules for the pharmaceutical and agricultural industries [7] - The company's proprietary generative AI engine, ChemPass AI™, is designed to generate highly potent, novel molecular candidates optimized across multiple critical parameters, improving success rates and reducing development time and costs [8][9] Scientific Advisory Board Contributions - Prof. John J. Irwin is recognized for his work in ligand discovery and virtual screening, having created widely used resources such as ZINC and DOCK, with over 35,000 citations [4] - Prof. Dan T. Major specializes in multiscale molecular modeling, integrating quantum mechanics and AI to accelerate drug discovery and ag-chemical development, with over 150 peer-reviewed publications [5] - Both professors will provide strategic guidance to ensure the accuracy, robustness, scalability, and applicability of ChemPass AI™ in real-world discovery programs [3][6] Strategic Goals - The appointments align with Evogene's Real-World Innovation approach, integrating deep scientific understanding with practical requirements in pharmaceutical and ag-chemical R&D [3] - The company aims to translate computational innovation into tangible value for the drug and ag-chemical industries through strategic partnerships and internal product development [9]